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Abstract 
In light of the ever-growing importance and usability of medical information systems (IS), the 
healthcare sector has been investing heavily in these technologies in recent years, with the aim of 
improving decision-making through improved medical processes, reduced costs and integration of 
medical data. However, these systems are extremely costly. In addition, the overall contribution of 
these technologies to the medical field is not obvious, especially, in high-stress environments such as 
emergency departments (EDs). The objective of this research is to explore whether investing in health 
information technology (HIT) in an ED is financially rewarding in general, and specifically the 
circumstances under which such an investment is more rewarding and vice versa. A cost-effectiveness 
analysis served as the selected tool for return on investment (ROI) estimations of certain integrative 
medical IS that serves seven main hospitals in Israel. We evaluated the overall profitability of this 
medical IS, by balancing the quality gained from information (retrieved from medical IS) against the 
costs of providing this information. 
The results of the cost-effectiveness analysis show that our specific medical cases of chest pain 
received a clear cost-effective reading since the results (∆Quality/∆Costs) were lower than the range 
of all common threshold values. Furthermore, the use of HIT in the ED improved the quality units per 
patient for each chosen admission decisions 
The findings of this study may also contribute to policy makers in the healthcare sector regarding the 
advisability of investing in such systems. 
Keywords: Cost-Effectiveness, Information Economy, Medical Decision-Making 
1. INTRODUCTION AND MOTIVATION 
The healthcare sector has been investing heavily in technologies in recent years, with the aim of 
improving medical decision-making through improved medical processes, reduced costs and 
integration of data on patients. Goldschmidt (2005) claimed that the increase in national health 
expenditures and the desire to improve the quality of healthcare are driving the widespread adoption of 
health information technology (HIT). Indeed, information retrieved by information systems can also 
improve the quality of the decisions made and reduce the risks and uncertainties that stem from the 
lack of information (Ahituv et al. 1994). By sharing real-time information, medical staff can make 
critical decisions resulting in safer and more efficient care. However, the new integrative medical IS 
are extremely costly. In addition, as the productivity paradox suggests, the overall contribution of 
information technologies to the field is not always immediately obvious (Brynjolfsson et al. 1996, 
Brynjolfsson 1993). Their impact on high-stress environments such as healthcare emergency 
departments (EDs), which often have to deal with an enormous number of patients under heavy time 
constraints, is even less obvious. The overcrowding in EDs often results in inferior clinical outcomes 
and reported medical errors in many aspect of emergency care, including: diagnostic errors, 
malfunctioning administrative procedures and wrong documentation (Fordyce et al. 2003, Hwang et 
al. 2004). Many of these malfunctions may have been prevented by using medical IS. Testing the 
contribution of medical IS is therefore a difficult and complex matter, as is estimating their return on 
investment (ROI). The purpose of this study was to examine the current performance of integrative 
medical systems and the capacity of medical IS to contribute to the field under the constraints of EDs. 
This purpose was accomplished by conducting a cost-effectiveness analysis of medical IS as the 
selected tool for ROI estimations.  
2. BACKGROUND 
The effects of medical information systems at the point of care have been studied in previous 
researches from different aspects. Yet, despite the increasing use of these systems by clinicians, there 
has been little research documenting the effectiveness of their use. Especially rare are studies dealing 
with the impact of online medical systems on decision-making in the stressful ED environment. 
The impact of using HIT on medical decision-making has been studied in many past researches 
(Westbrook et al. 2005, Redelmeier et al. 1995, Lejbkowicz et al. 2004). Additionally, general 
implications and outcomes of HIT have been studied in order to determining diagnostic and 
therapeutic strategies (Shortliffe 1987, Wyatt et al. 1990) and measuring the effectiveness of triaging 
patients in the ED by using medical IS (Michalowski et al. 2005, Michalowski et al. 2007). 
Goldschmidt (2005) claims that though until recently the field of HIT has been mostly the realm of 
enthusiasts, and the future trends include a vision that HIT can transform the healthcare system – 
thereby simultaneously improving quality and productivity. He concluded that the increase in national 
health expenditures and the desire to improve the quality of healthcare are driving the widespread 
adoption of HIT but we should further research their outcomes. 
There are few works that studied the financial implications and the outcomes of HIT, however, this 
topics are getting more academic attention only during the last years. For instance, theoretical 
frameworks to assess the potential value of medical information have been established only in the 
recent years (Claxton et al. 2005, Basu et al. 2007). Claxton (2002) and Walker et al. (2005) assessed 
the value of information exchange and interoperability between healthcare providers and other 
providers such as: independent laboratories, radiology centers and pharmacies. They showed that 
interoperability between these organizations would enable reduction of redundant tests, delays and 
additional costs. Shabtai et al. (2007) evaluated the contribution of HIT to improvement in the medical 
decision-making and concluded that: physicians with different expertise use different information 
components and that medical history of patients can improve decision-making and its outcomes. 
An important issue to mention in our research is the general implications of special HIT, the electronic 
medical record (EMR) systems. EMRs are usually accessed via a computer, often over a network. It 
may be constructed of many different locations and sources. Among the many forms of data often 
included in EMRs are patient medical history, chronic drugs, allergy lists, laboratory test results, and 
billing records. Ovretveit et al. (2007) stated that there is little research and a lack of theory about 
implementation of EMR systems and the measurements of its financial rewording.  
The literature survey leads us to various implicit and explicit recommendations for further research. 
One of the main avenues for further research in previous research is the economic evaluations of 
implementing IT in the healthcare sectors. Additionally, by following recent trends, we investigated 
the relationship between the use of medical IS and both of the financial and medical outcomes. 
3. RESEARCH QUESTION 
The objective of this research is to explore whether investing in HIT in an ED is financially rewarding 
in general, and specifically the circumstances under which such an investment is more rewarding and 
vice versa. Hence, the main research question is:  What is the ROI of integrative medical IS? 
A cost-effectiveness analysis served as the selected tool for ROI estimations of certain integrative 
medical IS that serves seven main hospitals in Israel. The cost-effectiveness analysis was conducted 
by balancing the quality gained from information regarding past medical history against the costs of 
providing that information. The analysis was based on the two most frequent chest pain ED cases, and 
compared the assessment of the results against total investments in the system. 
4. METHODOLOGY 
The assessment of the cost-effectiveness of our medical IS was carried out after two main stages:  
• Performing an experimental study using our analytical model – We performed controlled 
experiments that simulate the complicated reality of an ED environment, representing the main 
decision process in EDs (whether to admit or discharge the patient). 
• Developing a theoretical analytical model that represents the admission decision in EDs – We 
developed our model using medical decision trees as used by Golan et al. (2005) and Dotan et al. 
(2009) and as presented by Pauker et al. (1987), for evaluating the expected value of the medical 
IS. The evaluation of this normative value of information was based on the medical literature and 
on the clinical decisions made by physicians who participated in our experimental study. 
• Comparing the results of the experimental study and the analytical model and conducting a cost-
effectiveness using the results of the two former stages. 
4.1 The Experimental Study 
In the experimental study, we compared the performance of physicians who had access to complete 
clinical information on patients to that of physicians who lacked such access. The main stages were: 
• Selecting the medical scenarios – The cases have been chosen from the most common clinical 
scenarios in the national center for health statistics (NCHS1). The selected scenarios also appeared 
on the books of the educational commission for foreign medical graduates2 (ECFMG) in order to 
be recognized as having optimal credibility. According to the NCHS, we chose the most common 
specific principal reason given by adult patients for visiting the ED, the chest pain. 
                                                           
1
 NCHS is the United States' principal health statistics agency. It designs and maintains a number of systems that produce 
data related to health concerns. See at: http://www.cdc.gov/nchs 
2
 The ECFMG assesses the readiness of international medical graduates to enter residency or fellowship programs in the 
USA. See at: http://www.ecfmg.org 
• Constructing the medical scenarios - The cases were developed by a panel of six senior physicians 
in cooperation with an international medical simulation center (MSR institution3) and were 
finalized with a pilot study. The technical data have been added to the ECFMG instructions from 
previous relevant researches on chest pain and on acute myocardial infraction (AMI) differential 
diagnosis (DD) (Goldman et al. 2003, Lee et al. 2000, Panju et al. 1998, Pope et al. 2000). 
• The research took place in the form of a website-based application. The tested physician randomly 
received three cases with one of the following access patterns: with a full access to the medical IS 
or lack of any access to the medical IS. The physician decided on the medical strategy including: 
viewing the medical history and the physical examination, designing the diagnostic workup plan 
and deciding on the main DD and whether to admit or discharge the patient. 
4.2 The theoretical analytical model 
We begin this section with a presentation of our decision tree (most of the explanations of the 
calculations in the tree are not shown here in order to avoid data overload). We then provide 
explanations on our selected payoff approach, the general expected utility (EU) using the quality 
adjusted life years (QALY) measurement. Finally, we conduct the cost-effectiveness analysis. 
Discussion on the use of expected utility and the threshold decision 
We wish to initiate a discussion on the payoff of each alternative, by using the EU method. Figure 1 
shows the main decision node of our model: 
 
Guyatt et al. (2006) have emphasized the 
importance of the threshold-value approach (in 
accordance with Pauker et al. 1980, Pauker et al. 
1987) on medical resource allocation issues. 
Similarly, we used one threshold probability 
(having the AMI disease), which represents an 
indifference point between admission and 
discharge decisions. We added a few more 
variable definitions as follows: 
Figure 1. Admission decisions and general utilities 
P
- The probability of having the AMI DD. This threshold probability could be calculated by 
comparing the EU of admission to the EU of discharge: )()( UEUE DA =  
)(UEA
 - The EU of an admission decision; )(UED  - The EU of a discharge decision. 
According to figure 1, The EU of admission and discharge would be calculated as follows:  
Admit EU: 1211 )1()( UPUPUE A ⋅−+⋅= ;  Discharge EU: 2221 )1()( UPUPUE D ⋅−+⋅=  
Payoff by the QALY approach using Markov model 
The QALY is a measure used worldwide in the medical research field, based on the principle that a 
year of poor health is of lower utility than a year of life with a good health quality. QALY units are 
used to measure improvement in health care, while combining the predicted life expectancy with 
ethical values (Williams 1995). The QALY is also a common choice in decision analysis and in cost-
effectiveness studies (Weinstein 2006). We will explain the impact of the QALY utilities on the 
medical paradox question of whether to admit or discharge a patient. We implemented the decision 
tree using a Markov model to estimate the differences between individuals admitted and discharged 
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 MSR organization, the Israel international center for medical simulation,. See at: http://www.msr.org.il 
from the ED, in order to simulate the long-term progression of diseases via examination of the events 
associated with an ongoing risk (Sonnenberg et al. 1993, Sesso et al. 2003). We included assessments 
of the probabilities and the outcomes of the decision tree by using this approach. 
We implemented a Markov model to estimate the differences between individuals admitted and 
discharged from the ED. The basic assumption of these models is that each individual belongs, at any 
given time, to one of a finite number of health states, which allows for transitions from one health state 
to another during a predefined interval of time (Sesso et al. 2003). We used the model based on the 
possible transitions between the predefined health states outlined by Sesso et al. (2003) for the 
progression of cardiovascular disease (CVD) as follows: "No CVD", no history of CVD; "CVD", 
history of a CVD-related event. The transition from "No CVD" state to "CVD" state occurs via an 
event of a non fatal stroke (STRK), nonfatal AMI (MI), or via revascularization (RV). There are 
additional assumptions in integrating the Markov model: 
• Transitions between health states occur only as depicted above. Additionally, secondary CVD-
related events may occur more than once (Sesso et al. 2003, Dotan et al. 2009). 
• Firstly, the probability of a secondary CVD-related event is independent of the type of preceding 
CVD events. Secondly, after a period of 6 months from the primary event, secondary events occur 
at a constant annual rate (D’Agostino et al. 2000, Sesso et al. 2003). Finally, for patients starting 
in the "No CVD" state and the "CVD" state, we used the data from these primary prevention 
studies to estimate the risk of primary CVD events, secondary CVD events and death.  
• We also used the data available in major registries (Mooe et al. 1997, Rothwell et al. 2005) and in 
life-tables published by the NCHS (http://www.cdc.gov/nchs) to calibrate the rates of mortality. 
Figure 2 shows the structure of the tree for the QALY analysis using Markov model. 
 
 
Figure 2. The decision tree using QALY Approach and Markov model 
Assessments of the probabilities and the outcomes 
We further clarify the related assessments of the probabilities and the outcomes that have been added 
to the tree as a result of the integration with the Markov Model. 
The AMI probabilities: 
P_AMI_With_HI: The probability in the case where the DD is AMI (D+) when history was 
available and after a negative result was obtained from both of the examinations used in our 
experiment (electrocardiogram (ECG) as T1 and cardiac enzymes (CE) as T2). Hence, the results of 
the post-prior probability ( )−−+ 21TDP T  (calculated by the following equations and the appropriate values 
from the experimental study) when history was available are: 
In experiment case number 1: 9.6%. The range for sensitivity analysis: [5% - 15%]  
In experiment case number 2: 2.1%. The range for sensitivity analysis: [0.5% - 5%] 
These are the post prior probabilities equations: 
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Letting: 
( ) 11 DTP senT=++ - The sensitivity4 of the T1 examination (ECG).  
( ) 11 DTP speT=−− - The specificity5 of the T1 examination (ECG). 
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P_AMI_Without_HI: The probability in the case where the DD is an AMI (D+) when history was 
not available (after a negative result was obtained from both of the examinations (ECG as T1 and the 
CE as T2) in experiment case # 1, and, when a positive result was obtained from the ECG examination 
and a negative result was obtained from the CE examination in experiment case # 2). Hence: 
In case 1: the post-prior probability ( )−−+ 21TDP T  derived from the calculations of equations shown 
above, when history was not available is: 0.5%. The range for sensitivity analysis: [0.1% - 5%].  
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 Sensitivity of medical examination - The sensitivity measures the proportion of actual positives which are correctly 
identified in the medical examinations (i.e. the percentage of sick people who are identified as having the condition). 
5
 Specificity of medical examination - The specificity measures the proportion of negatives which are correctly identified in 
the medical examinations (i.e. the percentage of healthy people who are identified as not having the symptoms). 
In case 2, the post-prior probability ( )−++ 21TDP T  derived from the calculations of equations shown above, 
when history was not available is: 38.7%. The range for sensitivity analysis: [30% - 46%]. 
P_Die_AMI: The probability of a death of a patient within 30 days in the case where the DD is AMI 
(D+). In our study this probability has two options that are derived from the admission decision: 
P_Die_AMI_Admin and P_Die_AMI_Discharge: 
P_Die_AMI_Admin - The probability of a death of a patient within 30 days in the case where the DD 
is AMI (D+) when a decision to admit was made. 
We chose to adopt a mortality ratio within 30 days from Pope et al. (2000)'s large data set which was 
appropriate and in the range of mortality rates of other studies as well. We set the P_Die_AMI_Admin 
to 5.7%. The range for sensitivity analysis: [3.5% - 7.9%]. 
P_Die_AMI_Discharge - The probability of a death of a patient within 30 days in the case where the 
DD is AMI (D+) when a discharge decision was made. 
We used the previous research that explored the relationships between the two derived probabilities of 
P_Die_AMI, since the direct probability without using this relationship was very difficult to find in the 
literature. The risk-adjusted mortality ratio amongst discharged patients with AMI is about twice (1.9) 
as much as the risk-adjusted mortality ratio amongst admitted patients with AMI within 30 days (Pope 
et al. 2000). Consequently, we set the P_Die_AMI_Discharge to 10.83% (2* P_Die_AMI_Admin= 
5.7%*1.9). The range for sensitivity analysis: [8% - 14%].  
The Markov model probabilities and outcomes 
The rates used in our model (edited in table 3 below) were extracted from many clinical studies listed 
in the Meta analysis made by Dotan et al. (2009). During the simulation (i.e, at runtime), we converted 
these rates to probabilities by using the method described by Disch et al. (1994), in the form of 
triangular distributions, to generate probabilities within the Monte Carlo simulations, as proposed by 
Hunink et al. (2001). Table 3 below shows these event rates computed at runtime according to a 
triangular distribution and a decreasing life expectancy. 
The outcomes are consisted of the utilities in QALY units (to measure the "effectiveness"). Table 3 
(below) represents the utilities in QALY units per year (ranging from 0 – death until 1 – healthy lives). 
QALY values were computed according to the procedure described by Muennig et al. (2001): using 
the accepted preference scores catalogue "The Cost-effectiveness Analysis Registry" (CEA6).  
The cost-effectiveness analysis was performed in our study by balancing the QALY units gained as 
the beneficial effect of admission decision according to the disease conditions against the expected 
costs (Gudex et al. 1988, Pliskin et al. 1999, Golan et al. 2005, Guyatt et al. 2006) and by using a 
Markov model (Shamir et al. 2006, Leshno et al. 2003). The only missing part for performing such 
analysis is the details about the costs: 
The evaluation of the costs associated with admission decisions 
In general, acute care costs include hospitalization and any other related services such as ambulance, 
physician services, and rehabilitation costs, ordering and performing medical tests. In all of the 
medical scenarios we did not include the administrative referral costs. In order to properly evaluate the 
additional costs in US Dollars per year, we used secondary data from several recent studies (Fitch et 
al. 2007, Caro et al. 2007, Heeg et al. 2007, Grines et al. 1998) and we used a second assessments of 
experts and price-lists from the Israel Ministry of Health on this data from the studies mentioned 
above. These costs per first year including derived operations for each admission decision are 
presented in table 3 below with a wide range for sensitivity analyses. 
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 See at: https://research.tufts-nemc.org/cear/Default.aspx 
5. FINDINGS 
5.1 The Experimental Study 
The experiments were performed on 102 real physicians. Dealing with real practical decision-makers 
increases the external validity (Jarvenpaa et al. 1985). 53 physicians were provided with an access to 
the medical IS and 49 physicians were not provided with an access to the medical IS in the 
experiments. The difference in the number of physicians with and without access to the medical IS is 
due to the random access patterns of the medical IS. In general we had three simulated cases: 
• In case number 1, without any additional information from the medical IS, the normative medical 
decision of the physician should be to discharge this patient and the main DD is not one of the 
diagnoses related to AMI. On the contrary, with additional information from the medical IS, the 
normative medical decision of the physician should be to admit this patient and the main DD is 
one of the diagnoses related to AMI. 
• In case number 2, without any additional information from the medical IS, the normative medical 
decision of a physician should be to admit this patient and the main DD is one of the diagnoses 
related to AMI. On the contrary, with the additional information from the medical IS, the 
normative medical decision of the physician should be to discharge this patient and the main DD 
is not one of the diagnoses related to AMI. 
• In case number 3, which serves as a control case, in both cases (with or without additional 
information from the medical IS) the normative medical decision of the physician should be to 
admit this patient and the main DD is one of the diagnoses related to AMI. Case no. 3 was verified 
to serve as a control case in our results and is not shown here in order to avoid data overload.  
The term "medical history" below concerns to the additional information gained from the medical IS 
only for physicians who received an access to it. For other physicians, they were exposed only to the 
major complaint and to the limited demographic data which were equally provided to all the 
participants. We compared the number of admission decisions made by the physicians, of patients with 
medical history which was not viewed, and patients with medical history which was viewed.  
 
p-value Increase in Admissions7 
Percentage of Admissions when 
Medical History Was Viewed 
Percentage of Admissions when 
Medical History Was Not Viewed 
<0.001 142.7% 88.7% (47 physicians) 36.7% (18 physicians) 
Table 1. Case 1: Comparing proportions admission rates 
 
p-value Decrease in Admissions 
Percentage of Admissions when 
Medical History Was Viewed 
Percentage of Admissions when 
Medical History Was Not Viewed 
<0.001 35.54% 56.6% (30 physicians) 87.8% (43 physicians) 
Table 2. Case 2: Comparing proportions admission rates 
Summary of the main findings: 
A review of medical history contributes to admission decisions. Not only does it clearly reduce the 
number of unnecessary admissions (case 1), but it also increases the necessary admissions (case 2). In 
addition, the experiment results supported our theoretical results (in section 5.2) by supplementing 
statistical significance 
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 The result of 36.7% represents the number of physicians who had an admission decision in case 1, when medical history 
was not viewed (18) as a percentage of all participated physicians when medical history was not viewed in case 1 (49). And 
as a result: 18/49=36.7%. The increase in the admissions rate is calculated as the difference in the percentage of admissions 
between the situations without and with view of medical history. And as a result: (36.7%-88.7%)/36.7%=142.7%.  
5.2 The cost-effectiveness ( COSTSQALY ∆∆ / )  
In this section, we firstly show the variable values including the range for sensitivity analyses and 
secondly, we compare the results (in a manner of QALY units) between the two admission decisions 
(admit and discharge). Finally, we test the correspondence between our QALY results and the 
statistical empirical results in the experiment (shown above). We focused on the branch with the 
availability of information via the IS, although in figure 2, we also showed the other branch (without 
access to the medical IS). Here are the variable values including the range for sensitivity analyses: 
 
Range for 
sensitivity analysis Value Definition Variable 
Case 1:[5% - 15%] 
Case 2:[0.5% - 5%] 
Case 1: 9.6% 
Case 2: 2.1% 
The probability of having AMI when 
History was available P_AMI_With_HI 
Case1:[0.1% - 5%] 
Case 2:[30% -46%] 
Case 1: 0.5% 
Case 2: 38.7% 
The probability of having AMI when 
History wasn't available P_AMI_Without_HI 
[3.5% - 7.9%] 5.7% 
The probability that the patient dies within 
30 days after having AMI when a decision 
to admit was made 
P_Die_AMI_Admin 
[8% - 14%] 10.83% 
The probability that the patient dies within 
30 days after having AMI when a decision 
to discharge was made 
P_Die_AMI_Discharge 
Markov Model: Primary and Secondary CVD (expressed in terms of annual events per 1000) 
1.11 – 13.25 7.18 Non-CVD death (Primary CVD) 
0.26 – 4.55 2.4 CVD death (Primary CVD) 
0.18 – 2.72 1.45 Myocardial infarction (MI) (Primary CVD) 
0.87 – 1.43 1.15 Nonfatal stroke (Primary CVD) 
0.37 – 1.19 0.78 Revascularization (Primary CVD) 
6.06 – 15.91 10.98 Non-CVD death (Secondary CVD) 
11.38 – 19.26 15.32 CVD death (Secondary CVD) 
9.08 – 14.46 11.77 Myocardial infarction (MI) (Secondary CVD) 
7.85 – 9.5 8.67 Nonfatal stroke (Secondary CVD) 
Markov Model: Utility (in QALY units per year) 
- 0 The patient Admitted or discharged and died 
- 1 Discharge decision after Non-AMI DD 
0.998 - 1 0.999 Admission decision after Non-AMI DD (redundant) 
The patient Admitted or discharged after Non-AMI DD and lived (in QALYs per year in Markov Model) 
0.5 – 0.7 0.7 History of MI 
0.2 – 0.7 0.4 History of Stroke 
0.14 – 0.43 0.29 History of both Stroke and MI 
The additional costs in US Dollar per year used (including admissions and derived operations) 
5,000$ – 20,000$ 15,000$ Costs when an 'admit' decision was made after AMI DD 
300$ - 1,000$ 500$ Costs when an 'admit' decision was made after non-AMI DD (redundant) 
2,750$ – 11,000$ 8,250$ Costs when a 'discharge' decision was made after AMI DD 
- 0$ Costs when a 'discharge' decision was made after non-AMI DD 
Table 3. Variable Values and Sensitivity Analysis 
For the analysis of the experiment results, we used the "TreeAge Pro" program in order to analyze the 
decision tree (shown in figure 2) with the outcomes QALY units and with the costs. 
Findings from case 1: 
• The additional QALY units per admitted patient (justified) to the hospital resulting from review of 
medical history are measured as the difference between the decision to admit and the decision to 
discharge, resulting in: 22.2611 – 22.2008 = 0.0603 QALY units. These findings correspond, in 
the dominancy of admission decision, with the findings of the experimental study. The results of 
our sensitivity analysis further validate our findings due to many changes in our variables 
including Monte Carlo simulation on 100,000 trials (average ∆QALY=0.064). Meaning that the 
use of medical IS during the period of treatment in the ED improves the QALY units per patient.  
• The additional costs per admitted patient to the hospital resulting from review of medical history 
were measured as the difference between the decision to admit and the decision to discharge 
resulting in: 1,904.43$ – 792$ = 1,112.43$. The more costly option is to admit the patient as 
expected. 
 
Admission 
Decision 
QALY Per patient 
(Life-Expectancy) 
Costs 
Per patient ($) 
∆QALY 
Per patient 
∆ C 
Per patient ∆C/∆QALY 
Admit 22.2611 years 1904.43$ 
0.0603 1112.43$ 1112.43$/0.0603 
=18448.26$ Discharge 22.2008 years 792$ 
Table 4. Case 1: Cost-Effectiveness Analysis 
Findings from case 2: 
• The additional QALY units per discharged patient (justified) from the hospital resulting from 
review of medical history are measured as the difference between the decision to admit and the 
decision to discharge resulting in: 32.615 – 32.610 = 0.005 QALY units. These findings also 
correspond, with the findings of the experimental study. The results of the sensitivity analysis 
further validate our findings including Monte Carlo simulation on 100,000 trials, which yielded 
similar results (average ∆QALY=0.007). Meaning that the use of medical IS during the period of 
treatment in the ED improves the QALY units per patient.  
• The additional costs per discharged patient resulting from review of medical history were 
measured as the difference between the decision to admit the patient and the decision to discharge 
the patient resulting in: 185.68$ – 804.5$ = -618.82$ (saving 631.25$). The least costly option is 
to discharge the patient, meaning that the discharge decision in this case using the medical IS is 
the most optimal. 
 
Admission 
Decision 
QALY Per patient 
(Life-Expectancy) 
Costs 
Per patient ($) 
∆QALY 
Per patient 
∆ C 
Per patient ∆C/∆QALY 
Admit 32.615 years 185.68$ 
0.005 -618.82$ Cost-Saving 
Discharge 32.610 years 804.5$ 
Table 5. case 2: Cost-Effectiveness Analysis 
Discussion on the cost-effectiveness analysis results  
The main question is: what the affordable cost threshold value is made for adoption of medical IS. In 
general, in strategic policy decision-making in the healthcare sector there are accepted rules in health 
economics policies as explained here below. According to Medicare8 organization, any investment in 
medical accessory, medicine or treatment which led to improvement has a cost-effectiveness threshold 
of 50,000$ for gaining one QALY unit per patient (below 50,000$ it is very cost-effective). The 
                                                           
8
 See at: http://www.medicare.gov/ 
standard practice of Medicare is not a comprehensive practice but rather a minimal threshold for 
benchmark values. Many studies and organizations have set higher threshold values for which medical 
intervention is financially justifiable (such as: Hirth et al. 2000, Devlin et al. 2004). According to the 
World Health Organization9 (WHO), an intervention is considered to be (all monetary values are in 
2008 values in Israel): 
• Cost-Saving: if treatment costs averted exceed intervention costs. 
• Very Cost-Effective: if costs per QALY saved ≤ per capita GNP (around $27,000). 
• Cost-Effective: If costs per QALY saved ≤ 3 x per capita GNP (around $81,000). 
• Not Cost-Effective: If costs per QALY saved > 3 x per capita GNP (around $81,000). 
Our results varied in both of the medical cases. In case 1, the additional costs per patient per one 
QALY unit as a result of using integrative medical IS is 18,448.26$ (very cost-effective), and in case 
2, the saved costs per patient per one QALY unit as a result of using integrative medical IS is 618.82$ 
(cost-saving). Consequently, in our study, both of our special medical cases of chest pain received a 
clear cost-effective reading, since the results were lower than the range of the threshold values. Hence, 
in our specific cases, the investment in our integrative medical IS seems to be financially worthwhile. 
6. CONCLUSIONS 
Our findings lead to these major conclusions: 
• Investing in an integrative medical IS is financially worthwhile (cost-effective and even cost-
saving), provided that medical history was supplied to the physicians at the point of care of an ED 
during the triage of the patients in our specific cases of chest pain formulated in our experiments. 
• The use of integrative medical IS during the period of treatment in the ED improves the QALY 
units per patient for each chosen medical decisions. 
7. CONTRIBUTION AND LIMITATIONS 
The main purpose of our research was to contribute to scientific knowledge by providing additional 
insight into the various fields such as: information economics. We enumerate two main contributions: 
• Review of medical history contributes to admission decisions. This contribution was discovered 
both in the theoretical normative model and also in the course of an experimental study. 
• Proving cost-effectiveness for the use of integrative medical IS by using a Markov model and 
investigating the famous productivity paradox (Brynjolfsson et al. 1996, Brynjolfsson 1993) in the 
healthcare sector. 
The findings of this study may also contribute to policy makers in the healthcare sector regarding the 
advisability of investing in such systems and managing them. 
It is important to note the limitation that our findings related only to our specific experimental cases, 
which represent accepted and very frequent scenarios in the medical literature. However, these 
theoretical cases are quite limited in the generalization option. Hence, although we believe our results 
are valid, further research is advisable on this subject. 
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